Good Life Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,666
| Closed | -$388K | – | 541 |
|
|
2024
Q3 | $388K | Buy |
2,666
+993
| +59% | +$145K | 0.02% | 400 |
|
|
2024
Q2 | $230K | Buy |
1,673
+93
| +6% | +$12.8K | 0.02% | 402 |
|
|
2024
Q1 | $217K | Sell |
1,580
-15
| -0.9% | -$2.06K | 0.02% | 410 |
|
|
2023
Q4 | $217K | Buy |
+1,595
| New | +$217K | 0.02% | 398 |
|
|
2023
Q3 | – | Sell |
-1,585
| Closed | -$201K | – | 422 |
|
|
2023
Q2 | $201K | Sell |
1,585
-96
| -6% | -$12.2K | 0.02% | 385 |
|
|
2023
Q1 | $217K | Hold |
1,681
| – | – | 0.03% | 348 |
|
|
2022
Q4 | $221K | Sell |
1,681
-186
| -10% | -$24.4K | 0.03% | 311 |
|
|
2022
Q3 | $218K | Sell |
1,867
-255
| -12% | -$29.8K | 0.03% | 300 |
|
|
2022
Q2 | $250K | Hold |
2,122
| – | – | 0.03% | 292 |
|
|
2022
Q1 | $276K | Sell |
2,122
-143
| -6% | -$18.6K | 0.03% | 301 |
|
|
2021
Q4 | $346K | Buy |
2,265
+303
| +15% | +$46.3K | 0.04% | 262 |
|
|
2021
Q3 | $317K | Buy |
+1,962
| New | +$317K | 0.04% | 260 |
|